1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Digestive tract conditions
  5. Inflammatory bowel disease

Inflammatory bowel disease

  • Register as a stakeholder

Research Recommendations

  • Surveillance programmes for people at increased risk of colorectal cancer:- How effective are colonoscopic surveillance progr...
  • Natural history of progression to colorectal cancer in people at increased risk:- What is the natural history of progression ...
  • Effectiveness of biomarkers for determining level of risk of colorectal cancer:- Which biomarkers, including epigenic and gen...
  • Adenoma types and risk of colorectal cancer:- Does the risk of colorectal cancer depend on the type of adenoma?
  • Azathioprine:- For patients with intestinal Crohn's disease, does the addition of azathioprine to glucocorticosteroid treatme...
    October 2012
  • Enteral nutrition:- What are the benefits, risks and cost effectiveness of enteral nutrition compared with glucocorticosteroi...
    October 2012
  • 5-aminosalicylate (5-ASA) treatment:- Following successful medical induction of remission of Crohn's disease of the colon, is...
    October 2012
  • Surgery versus medical treatment for the distal ileum:- What is the effect on quality of life of medical treatment (immunosup...
    October 2012
  • Patient information and support:- What are the information needs of people with Crohn's disease, as defined by people with th...
    October 2012
  • Induction of remission for people with moderate ulcerative colitis: prednisolone compared with
    aminosalicylates:- What i...
    July 2013
Full List

Shared Learning

  • Implementing faecal calprotectin testing in primary care
    November 2015
  • Evaluation of guidelines for the use of faecal calprotectin testing in primary care
    August 2015
  • Therapeutic Review- A NICE way to optimise prescribing
    January 2014

Do not do

  • Do not offer a conventional glucocorticosteroid or budesonide to maintain remission.
    October 2012
  • Do not routinely monitor for changes in bone mineral density in children and young people.
    October 2012
  • Guidance
  • Resources
    • Savings and productivity
    • Local practice
NICE
  • About NICE
  • Into practice
  • News
  • Contact us
  • Leave feedback
  • Jobs
  • Newsletters and alerts
  • Blog
  • Twitter
  • YouTube
  •   Facebook
  • LinkedIn

Explore

  • Guidance
  • Pathways
  • Standards and indicators
  • Savings and productivity
  • Evidence search
  • BNF
  • BNFC
  • Clinical knowledge summaries
  • Journals and databases

Reusing our content

  • Reuse information
  • NICE UK Open Content Licence

Guidance app

  • Android
  • iOS

Get involved

  • Register as a stakeholder
  • Citizens council
  • Consultations
  • Fellows and scholars
  • Join a committee
  • Meetings in public
  • Student champions
  • Tenders
  • Public involvement
  • Accessibility
  • Freedom of information
  • Syndication services
  • Glossary
  • Terms and conditions

Copyright © 2017 National Institute for Health and Care Excellence. All rights reserved.